The global carrier screening market is estimated to reach USD 4.0 billion by 2024 from USD 1.8 billion in 2019, at a CAGR of 17.5% during the forecast period. Growth in the carrier screening market can primarily be attributed to factors such as increasing emphasis on early disease detection & prevention of disease and technological advancements in carrier screening.
The major players in the carrier screening market include Invitae (US), Natera (US), Fulgent Genetics (US), LabCorp (US), and Sema4 (US). These players have adopted various growth strategies such as service & product launches, partnerships & collaborations, and expansions to increase their presence in the global carrier screening market.
To know about the assumptions considered for the study download the pdf brochure
Invitae (US) was one of the major players operating in the carrier screening market in the year 2018. The company’s major testing services include core, expanded, predesigned, and customized carrier screening testing panels. Invitae’s geographic presence is prominent in North American countries, which primarily focuses on offering carrier screening testing services. Since Invitae’s acquisition of Good Start Genetics in 2017, the company has significantly strengthened its position in the carrier screening testing market.
Fulgent Genetics (US) is among the leading players in the carrier screening market. The company provides a comprehensive carrier screening test portfolio of targeted & expanded carrier screening testing panels, which can be customized and predesigned as per requirements. Fulgent has a significant presence in the expanded carrier screening segment with a broad range of testing panels such as ACOG/ACMG Female Carrier Screening Panel, ACOG/ACMG Male Carrier Screening Panel, and Ashkenazi Jewish Female Carrier Screening Panel, among others. The presence of Fulgent’s company services in the APAC region will strengthen its footprint, majorly due to the presence of all carriers present in ethnic groups.
Carrier Screening Market by Product and Service, Type (Expanded Carrier (Predesigned, Customized), Targeted Disease Carrier), Medical Condition (Pulmonary, Hematological), Technology (Sequencing, PCR), End User, Region - Global Forecast to 2024
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE